Congenital heart malformations, also known as congenital heart defects (CHDs), encompass a spectrum of structural abnormalities in the heart that manifest at birth, originating during fetal development. These defects impact various components of the heart, including its walls, valves, and blood vessels, leading to disruptions in normal blood flow. The severity of CHDs can vary, with some posing minimal health risks while others demand immediate medical attention. The etiology of congenital heart malformations is multifaceted, involving a complex interplay of genetic factors, environmental influences, or a combination thereof. Recent strides in medical technology have revolutionized the landscape of prenatal screening, enabling the early detection of congenital heart malformations. This breakthrough facilitates timely intervention and treatment strategies, ultimately enhancing patient outcomes. Treatment approaches are diverse, tailored to the specific defect and its severity. They range from pharmaceutical interventions to intricate surgical procedures aimed at rectifying the structural anomalies.